Jubilant Ingrevia Ltd (BOM:543271)
₹ 707.6 +0.60 (+0.08%) Market Cap: 111.60 Bil Enterprise Value: 117.56 Bil PE Ratio: 36.40 PB Ratio: 3.57 GF Score: 81/100

Q4 2025 Jubilant Ingrevia Ltd Earnings Call Transcript

May 13, 2025 / 11:30 AM GMT
Release Date Price: ₹701.2 (-2.34%)

Key Points

Positve
  • Jubilant Ingrevia Ltd (BOM:543271) reported a significant increase in profit after tax, rising by 153% year-on-year.
  • The company achieved its highest ever EBITDA for specialty chemicals, with a 93% year-on-year growth.
  • The board recommended a final dividend of 250%, reflecting strong financial performance.
  • The company has maintained a strong market position, being the global leader in Pyridine and Picoline derivatives.
  • Jubilant Ingrevia Ltd (BOM:543271) has successfully increased its international revenue share to 45%, with a 47% year-on-year increase.
Negative
  • The chemical intermediate business segment experienced a decline in revenue due to ongoing challenges in the paracetamol market.
  • Pricing pressures remain in certain segments, particularly in the acetic anhydride business due to low demand.
  • Despite strong performance in specialty chemicals and nutrition, overall revenue was slightly lower compared to the previous year.
  • The company faces competition from Chinese imports, impacting pricing in certain segments.
  • There is a dependency on the recovery of the paracetamol and agrochemical markets for future growth in certain business segments.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

JUBN.NS - Jubilant Ingrevia Ltd
Q4 2025 Jubilant Ingrevia Ltd Earnings Call
May 13, 2025 / 11:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the Jubilant Engrave Limited Q4 NF 525 earnings conference call.

As a reminder, all participant lines will remain in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during the conference call, please signal the operator by pressing, then 0 on your touchstone telephone.

Please note that this conference is being recorded.

I now hand the conference over to Mr. Pavineja, head of investor relations at Jubilant Inquiry Limited.

Thank you and over to you, sir.

--------------------------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot